Complete pre-operative clearance including CBC, coagulation profile, and metabolic panel. Obtain standardized knee radiographs and MRI to assess lesion size and surrounding bone stock. Strict NPO (nothing by mouth) for at least 8 hours prior to surgery. Administer prophylactic intravenous antibiotics within 60 minutes of incision. Obtain informed consent and mark the surgical site.
Post-operative inpatient stay for pain management and physical therapy initiation. Utilize continuous passive motion (CPM) machines if indicated. Strict non-weight bearing or restricted weight-bearing status for 6-12 weeks depending on graft size/location. Transition to graduated physical therapy protocol focusing on range of motion and quadriceps strengthening. Monitor for signs of infection, neurovascular compromise, or graft failure. Discharge upon meeting physical therapy and pain control milestones.
Osteochondral Allograft Transplantation (OCA) of the Knee: A Comprehensive Clinical Guide
Osteochondral Allograft Transplantation (OCA) represents a sophisticated, biologic reconstructive strategy for the management of large, symptomatic osteochondral defects and articular cartilage lesions within the knee joint. Unlike autologous procedures that rely on harvesting healthy tissue from the patient’s own joint, OCA utilizes donor tissue to restore the complex architecture of hyaline cartilage and subchondral bone. This guide serves as an authoritative resource for clinicians and medical professionals regarding the indications, technical execution, and postoperative management of this procedure.
1. Overview and Mechanism of Action
The Biological Rationale
The primary challenge in managing articular cartilage defects is the inherent lack of vascularity, lymphatic drainage, and neural innervation in hyaline cartilage. When a defect extends into the subchondral bone (osteochondral defect), the body’s natural healing response is fibrocartilage formation, which lacks the biomechanical durability and friction-reducing properties of native hyaline cartilage.
OCA functions by transplanting a mature, viable, structural unit consisting of:
* Hyaline Cartilage: The load-bearing surface.
* Subchondral Bone: The structural foundation that supports the cartilage and facilitates osseous integration with the host.
Technical Specifications
The procedure involves the transplantation of fresh-stored allograft tissue. Fresh tissue is prioritized over frozen or cryopreserved options to maximize chondrocyte viability, which is essential for long-term integration and maintenance of the extracellular matrix.
| Feature | Description |
|---|---|
| Tissue Source | Fresh-stored cadaveric donor (typically <28 days post-harvest). |
| Integrity | Includes both the cartilage layer and the underlying subchondral bone. |
| Primary Goal | Restore anatomic contour and joint biomechanics. |
| Success Metric | Integration of bone graft to host bed and preservation of chondrocyte viability. |
2. Clinical Indications and Patient Selection
The identification of appropriate candidates is the most critical determinant of success. OCA is generally reserved for patients who have failed conservative management or less invasive surgical interventions.
Indications
- Large Defects: Lesions typically >2.0 cm² or those involving significant bone loss.
- Osteochondritis Dissecans (OCD): Residual defects following failed fixation or large, unrepairable craters.
- Post-traumatic Osteonecrosis: Localized bone death with collapse of the articular surface.
- Failed Prior Cartilage Surgery: Patients who have undergone microfracture, OATS (autograft), or ACI (autologous chondrocyte implantation) with suboptimal results.
- Bipolar Lesions: Cases where both the femoral condyle and the opposing tibial plateau require restoration.
Contraindications
- Advanced Osteoarthritis: Diffuse, multi-compartmental joint degradation (e.g., Kellgren-Lawrence Grade III-IV).
- Systemic Inflammatory Disease: Rheumatoid arthritis or active infection.
- Malalignment: Uncorrected mechanical axis deviation (varus or valgus) will lead to graft failure due to overload.
- Obesity: BMI >35 is often considered a relative contraindication due to increased shear forces on the graft.
3. Pre-Operative Preparation
Success in OCA requires meticulous preoperative planning, often utilizing advanced imaging.
- Imaging: MRI is essential for assessing lesion size, depth, and the state of the surrounding cartilage. Weight-bearing radiographs (long-leg films) are mandatory to assess mechanical axis alignment.
- Allograft Matching: Donor-recipient matching is performed based on skeletal size (height, weight, gender) and, increasingly, by using 3D-CT templating to ensure the donor graft matches the radius of curvature of the patient’s femoral condyle.
- Patient Optimization: Smoking cessation is strictly enforced to ensure bone incorporation. Physical therapy may be prescribed pre-operatively to optimize quadriceps strength.
4. The Surgical Procedure: Technical Steps
The procedure is performed under general or regional anesthesia, typically utilizing a tourniquet for a bloodless field.
Step-by-Step Execution
- Diagnostic Arthroscopy: Initial assessment of the joint to confirm lesion size and rule out unexpected pathology.
- Arthrotomy: A formal arthrotomy (medial or lateral parapatellar) is performed to provide sufficient exposure to the lesion.
- Lesion Preparation: The necrotic or damaged cartilage and bone are debrided back to healthy, bleeding subchondral bone. The defect is shaped into a circular or elliptical geometry (often using a "plug" or "shell" technique).
- Graft Preparation: The allograft is sized and cut to match the host defect. This is done on the back table, ensuring the donor bone fits the recipient bed with a press-fit or interference fit.
- Implantation: The graft is press-fitted into the defect. Stability is verified; the graft should be flush with the surrounding articular cartilage.
- Fixation: Depending on the size, some grafts may require headless compression screws (e.g., Herber screws) to ensure intimate contact between the graft and the host bone, facilitating osteointegration.
- Closure: Standard layered closure of the arthrotomy.
5. Post-Operative Recovery Protocol
The recovery timeline is divided into distinct phases to protect the graft while promoting healing.
| Phase | Duration | Focus |
|---|---|---|
| Phase I | Weeks 0-6 | Protected weight-bearing (NWB or TTWB), ROM exercises, edema control. |
| Phase II | Weeks 6-12 | Progressive weight-bearing, strengthening (quads/hamstrings), stationary bike. |
| Phase III | Weeks 12-24 | Return to functional activities, gait normalization, proprioception training. |
| Phase IV | Month 6+ | Return to impact activities (based on clinical progress and imaging). |
6. Complications and Risks
While OCA is a powerful tool, it is not without risk. Clinicians must counsel patients on the following:
- Infection: Risk of deep joint space infection (rare).
- Graft Resorption: Failure of the graft bone to integrate with host bone.
- Persistent Pain: Often related to underlying joint pathology or incomplete integration.
- Progression of Arthritis: OCA is not a cure for osteoarthritis; it is a treatment for a focal defect.
- Donor-Related Risks: Minimal risk of disease transmission (allograft tissue is strictly screened and processed by accredited tissue banks).
7. Alternative Treatments
When OCA is not indicated, other treatment modalities should be considered:
* Microfracture: Best for small (<1-2 cm²) lesions.
* Autologous Chondrocyte Implantation (ACI): A two-stage procedure using cultured cells.
* Osteotomy (HTO/DFO): For patients with malalignment, correcting the axis may delay the need for cartilage repair.
* Arthroplasty: For patients with end-stage, multi-compartmental arthritis.
8. Frequently Asked Questions (FAQ)
1. What is the success rate of OCA?
Success rates vary by location and defect size, but studies generally report 75–85% survivorship at 5–10 years post-operatively.
2. How long does the allograft last?
Because it is viable bone and cartilage, it is designed to last for decades, provided the joint alignment is correct and the patient does not have systemic arthritis.
3. Is there a risk of disease transmission?
Strict screening protocols by the American Association of Tissue Banks (AATB) make the risk of disease transmission from allografts extremely low (estimated at <1 in 1,000,000).
4. Can I play sports after OCA?
Yes, many patients return to high-impact activities. However, the timeline is long, often requiring 9–12 months of rehabilitation before returning to contact sports.
5. Why use fresh tissue over frozen?
Fresh tissue contains live chondrocytes. Frozen tissue devitalizes the cells, which may impair the long-term biological maintenance of the cartilage surface.
6. Do I need hardware?
Often, yes. Headless compression screws are used to secure the bone graft to the underlying host bone until biological incorporation occurs.
7. Does age affect the outcome?
While there is no strict age cutoff, biological age and the quality of the surrounding joint environment are more predictive of success than chronological age.
8. What happens if the graft fails?
Revision options include repeat OCA, ACI, or conversion to a partial or total knee arthroplasty.
9. How do I know if I am a candidate?
A consultation with an orthopedic surgeon specializing in sports medicine or joint preservation is required, involving a physical exam and specialized MRI imaging.
10. Is the surgery painful?
Post-operative pain is managed with a multimodal protocol (nerve blocks, NSAIDs, physical therapy). While the recovery is demanding, most patients report significant pain relief from their original defect once the graft integrates.
9. Clinical Conclusion
Osteochondral Allograft Transplantation (OCA) remains the "gold standard" for the biological restoration of large osteochondral defects in the knee. By providing a structural, viable, and anatomic match, OCA allows patients to return to active lifestyles while avoiding the morbidity associated with autograft harvesting. The success of this procedure hinges on rigorous patient selection, meticulous surgical technique, and strict adherence to the postoperative rehabilitation protocol. As regenerative medicine continues to evolve, the integration of OCA with biological adjuncts may further enhance the outcomes of this already powerful procedure.